Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Clinical Research Institute, American University of Beirut Faculty of Medicine, Beirut, Lebanon.
JAMA Ophthalmol. 2021 May 1;139(5):526-541. doi: 10.1001/jamaophthalmol.2021.0146.
More than 1 billion people worldwide have vision impairment or blindness from potentially preventable or correctable causes. Quality of life, an important measure of physical, emotional, and social well-being, appears to be negatively associated with vision impairment, and increasingly, ophthalmic interventions are being assessed for their association with quality of life.
To examine the association between vision impairment or eye disease and quality of life, and the outcome of ophthalmic interventions on quality of life globally and across the life span, through an umbrella review or systematic review of systematic reviews.
The electronic databases MEDLINE, Ovid, Embase, Cochrane Database of Systematic Reviews, Proquest Dissertations, and Theses Global were searched from inception through June 29, 2020, using a comprehensive search strategy. Systematic reviews addressing vision impairment, eye disease, or ophthalmic interventions and quantitatively or qualitatively assessing health-related, vision-related, or disease-specific quality of life were included. Article screening, quality appraisal, and data extraction were performed by 4 reviewers working independently and in duplicate. The Joanna Briggs Institute critical appraisal and data extraction forms for umbrella reviews were used.
Nine systematic reviews evaluated the association between quality of life and vision impairment, age-related macular degeneration, glaucoma, diabetic retinopathy, or mendelian eye conditions (including retinitis pigmentosa). Of these, 5 were reviews of quantitative observational studies, 3 were reviews of qualitative studies, and 1 was a review of qualitative and quantitative studies. All found an association between vision impairment and lower quality of life. Sixty systematic reviews addressed at least 1 ophthalmic intervention in association with quality of life. Overall, 33 unique interventions were investigated, of which 25 were found to improve quality of life compared with baseline measurements or a group receiving no intervention. These interventions included timely cataract surgery, anti-vascular endothelial growth factor therapy for age-related macular degeneration, and macular edema.
There is a consistent association between vision impairment, eye diseases, and reduced quality of life. These findings support pursuing ophthalmic interventions, such as timely cataract surgery and anti-vascular endothelial growth factor therapy, for common retinal diseases, where indicated, to improve quality of life for millions of people globally each year.
全球有超过 10 亿人因潜在可预防或可矫正的原因而视力受损或失明。生活质量是身体、情感和社会幸福感的一个重要衡量标准,它似乎与视力受损呈负相关,而且越来越多的眼科干预措施正在被评估与生活质量的关系。
通过对系统评价的伞状评价或系统评价,研究全球范围内和整个生命周期中视力受损或眼部疾病与生活质量的关系,以及眼科干预对生活质量的影响。
从 2020 年 6 月 29 日起,通过对 MEDLINE、Ovid、Embase、Cochrane 系统评价数据库、Proquest 论文和全球论文进行全面检索,检索了电子数据库。纳入了定量或定性评估健康相关、视力相关或疾病特异性生活质量的解决视力障碍、眼部疾病或眼科干预问题的系统评价。4 名评审员独立并重复进行文章筛选、质量评估和数据提取。使用了乔安娜·布里格斯研究所的伞状评价批判性评价和数据提取表。
有 9 项系统评价评估了生活质量与视力障碍、年龄相关性黄斑变性、青光眼、糖尿病视网膜病变或孟德尔眼病(包括色素性视网膜炎)之间的关系。其中,5 项是定量观察性研究的综述,3 项是定性研究的综述,1 项是定性和定量研究的综述。所有研究都发现视力障碍与生活质量较低之间存在关联。有 60 项系统评价至少涉及 1 项与生活质量相关的眼科干预措施。总的来说,调查了 33 项独特的干预措施,其中 25 项被发现与基线测量或未接受干预的组相比,改善了生活质量。这些干预措施包括及时的白内障手术、抗血管内皮生长因子治疗年龄相关性黄斑变性和黄斑水肿。
视力障碍、眼部疾病和生活质量下降之间存在一致的关联。这些发现支持在全球范围内每年为数百万患者进行有针对性的眼科干预,例如及时的白内障手术和抗血管内皮生长因子治疗常见的视网膜疾病,以提高生活质量。